NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Price Target Raised to C$6.00 at BMO Capital Markets

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) had its price objective upped by investment analysts at BMO Capital Markets from C$5.00 to C$6.00 in a research report issued on Thursday,BayStreet.CA reports. BMO Capital Markets’ price target would indicate a potential upside of 8.30% from the stock’s previous close.

A number of other research firms also recently weighed in on NWH.UN. Scotiabank raised their price target on shares of NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a research report on Thursday. CIBC increased their price objective on shares of NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 in a research note on Thursday. One research analyst has rated the stock with a Buy rating, According to MarketBeat.com, NorthWest Health Prop Real Est Inv Trust currently has a consensus rating of “Buy” and a consensus price target of C$6.13.

NorthWest Health Prop Real Est Inv Trust Stock Down 3.1%

NWH.UN traded down C$0.18 on Thursday, reaching C$5.54. The company’s stock had a trading volume of 887,343 shares, compared to its average volume of 597,925. NorthWest Health Prop Real Est Inv Trust has a 1 year low of C$4.33 and a 1 year high of C$5.73. The business’s 50 day moving average is C$5.10 and its 200 day moving average is C$4.96. The company has a debt-to-equity ratio of 129.42, a current ratio of 0.25 and a quick ratio of 0.06. The stock has a market cap of C$1.38 billion, a price-to-earnings ratio of -13.22, a price-to-earnings-growth ratio of 0.74 and a beta of 1.46.

About NorthWest Health Prop Real Est Inv Trust

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.